Answers are grounded in this paper and cite their sources.
This study aims to determine 1) prevalence of metabolic syndrome (MetS) in adults with Down syndrome (DS), 2) whether MetS alters risk of dementia in adults with DS.
No takes yet. Share an insight, caveat, or question.
Dass et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: